HC Wainwright & Co. maintains Buy rating on Adicet Bio, $34 price target
HC Wainwright & Co. maintained their Buy rating on Adicet Bio's stock with a price target of $34.00.The price target implies an upside of 276.9% from the Sep 25 close of $9.02.Key takeaways from the analyst noteFavorable Safety Profile of Prula-cel: Adicet Bio's lead product candidate, prulacabtage…